SS
CPRX

Sunbelt Securities’s Catalyst Pharmaceutical CPRX Stock Holding History

Sunbelt Securities’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-300
Closed -$5.91K – 2821
2025
Q3 		$5.91K Buy
+300
New +$6.17K ﹤0.01% 1578
2024
Q1 		– Sell
-50
Closed -$840 – 1747
2023
Q4 		$840 Hold
50
– – ﹤0.01% 1557
2023
Q3 		$584 Hold
50
– – ﹤0.01% 1641
2023
Q2 		$672 Hold
50
– – ﹤0.01% 1566
2023
Q1 		$823 Buy
+50
New +$825 ﹤0.01% 1513
2020
Q1 		– Sell
-30,200
Closed -$113K – 422
2019
Q4 		$113K Hold
30,200
– – 0.01% 576
2019
Q3 		$160K Buy
+30,200
New +$161K 0.02% 533

Other funds holding CPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Sunbelt Securities's CPRX Position: Q4 2025 in Review

Sunbelt Securities sold out of Catalyst Pharmaceutical (CPRX) in Q4 2025, closing a stake of 300 shares — an estimated $5.91K sold.

Sunbelt Securities first reported a position in CPRX in Q3 2019 and held it in 7 quarters. The position peaked at $160K in Q3 2019. 373 funds tracked by Wall St. Rank hold CPRX as of Q4 2025.

  • Sunbelt Securities reported no remaining Catalyst Pharmaceutical position as of Q4 2025 after selling out during the quarter.
  • Sunbelt Securities sold 300 Catalyst Pharmaceutical shares in Q4 2025, an estimated $5.91K.
  • Sunbelt Securities first reported a position in Catalyst Pharmaceutical in Q3 2019 and held it in 7 quarters.
  • Sunbelt Securities's Catalyst Pharmaceutical position peaked at $160K in Q3 2019.
  • 373 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q4 2025.

Based on Sunbelt Securities's 13F filing for Q4 2025, filed 20 Feb 2026.